Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;16(6):765-72.
doi: 10.1007/s11307-014-0748-x.

Syntheses and radiosyntheses of two carbon-11 labeled potent and selective radioligands for imaging vesicular acetylcholine transporter

Affiliations

Syntheses and radiosyntheses of two carbon-11 labeled potent and selective radioligands for imaging vesicular acetylcholine transporter

Prashanth K Padakanti et al. Mol Imaging Biol. 2014 Dec.

Abstract

Purpose: The vesicular acetylcholine transporter (VAChT) is a specific biomarker for imaging presynaptic cholinergic neurons. The syntheses and C-11 labeling of two potent enantiopure VAChT inhibitors are reported here.

Procedures: Two VAChT inhibitors, (±)-2 and (±)-6, were successfully synthesized. A chiral HPLC column was used to resolve the enantiomers from each corresponding racemic mixture for in vitro characterization. The radiosyntheses of (-)-[(11)C]2 and (-)-[(11)C]6 from the corresponding desmethyl phenol precursor was accomplished using [(11)C]methyl iodide or [(11)C]methyl triflate, respectively.

Results: The synthesis of (-)-[(11)C]2 was accomplished with 40-50 % radiochemical yield (decay-corrected), SA > 480 GBq/μmol (EOB), and radiochemical purity >99 %. Synthesis of (-)-[(11)C]6 was accomplished with 5-10 % yield, SA > 140 GBq/μmol (EOB), and radiochemical purity >97 %. The radiosynthesis and dose formulation of each tracer was completed in 55-60 min.

Conclusions: Two potent enantiopure VAChT ligands were synthesized and (11)C-labeled with good radiochemical yield and specific activity.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest. The authors declare that they have no conflict of interest.

Figures

Scheme 1
Scheme 1
Syntheses of standard compounds (−)-2 and (+)-2. Reagents and conditions: a) 1a,2,7,7a-tetrahydronaphtho[2,3-b]oxirene, K2CO3, EtOH reflux, b) HPLC separation of enantiomers: Chiralcel OD column, mobile phase: 1 % hexane/20 % IPA70% MeOH; flow rate: 4.0 ml/min (+)-2 at 14 min and (−)-2 at 30 min.
Scheme 2
Scheme 2
Syntheses of enantiomers of (+)-6 and (−)-6, and the desmethyl counterpart (−)-7. Reagents and conditions: a) 1 eq. (BOC)2O, K2CO3, THF/H2O, 0 °C to rt, 66 %; b) N,O-dimethylhydroxylamine hydrochloride, NEt3, BOPCl, DMF, 0 °C to rt, overnight, 54 %; c) 5-bromo-2-methoxypyridine, BuLi, THF, −78 °C, 75 %; d) TFA, CH2Cl2, 98 %; e) 1a,2,7,7a-tetrahydronaphtho[2,3-b]oxirene, NEt3, MeOH, 24 %; f) Separation of enantiomers on chiral HPLC (Chiralcel OD 250×10 mm, mobile phase: 100 % acetonitrile, 4 ml/min), Rt (+)-enantiomer at 12 min and (−)-enantiomer at 18 min; g) TMSI, CHCl3, 55 °C, 99 %.
Scheme 3
Scheme 3
Synthesis of precursor (−)-9. Reagents and conditions: a) Conc. HCl, 100 °C, 8 days, 96 %; b) 1a,2,7,7a-tetrahydronaphtho[2,3-b]oxirene, K2CO3, EtOH, reflux, 4 days, 62 %; c) BnBr, K2CO3, acetone, 45 °C, overnight, 62 %; d) Separation of enantiomers of 10 on HPLC: Chiralcel OD column 250×10 mm; mobile phase: 60 % isopropanol in hexanes; flow rate: 4.0 ml/min; (+)-enantiomer at 22 min and (−)-enantiomer at 49 min; e) (−)-10, 10 % Pd/C, MeOH, 70 psi, 21 h, 90 %.
Scheme 4
Scheme 4
Radiosyntheses of (−)-[11C]2 and (−)-[11C]6.

Similar articles

Cited by

References

    1. Schliebs R, Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease. J Neural Transm. 2006;113:1625–1644. - PubMed
    1. Hilker R, Thomas AV, Klein JC, et al. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology. 2005;65:1716–1722. - PubMed
    1. Gilmor ML, Nash NR, Roghani A, et al. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J Neurosci. 1996;16:2179–2190. - PMC - PubMed
    1. Prado VF, Martins-Silva C, de Castro BM, et al. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron. 2006;51:601–612. - PubMed
    1. Rogers GA, Parsons SM, Anderson DC, et al. Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol) J Med Chem. 1989;32:1217–1230. - PubMed

Publication types

MeSH terms